×
About 170 results

ALLMedicine™ Autoimmune Pulmonary Alveolar Proteinosis Center

Research & Reviews  85 results

Expression profiles and potential functions of long noncoding RNAs and mRNAs in autoimm...
https://doi.org/10.18632/aging.202818
Aging Yang Y, Xu W et. al.

Apr 6th, 2021 - Autoimmune pulmonary alveolar proteinosis (APAP) is a rare lung disease that may be associated with surfactant overaccumulation. To assess the function of long noncoding RNAs (lncRNAs) in APAP, we performed microarray analyses to identify differen...

Autoimmune pulmonary alveolar proteinosis and idiopathic pulmonary haemosiderosis: a du...
https://doi.org/10.1136/bcr-2020-241048
BMJ Case Reports; Walsh L, McCarthy C et. al.

Apr 3rd, 2021 - Pulmonary alveolar proteinosis (PAP) is a rare pulmonary condition which leads to excessive accumulation of proteinaceous material within the alveoli. Idiopathic pulmonary haemosiderosis (IPH) is another orphan lung disease and results in recurren...

B cell-activating factors in autoimmune pulmonary alveolar proteinosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923513
Orphanet Journal of Rare Diseases; Hirose M, Arai T et. al.

Mar 3rd, 2021 - Autoimmune pulmonary alveolar proteinosis (APAP) results from the suppression of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling by a neutralizing autoantibody against GM-CSF. B cell-activating factor (BAFF) and a proliferation...

Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884840
Nature Communications; Sakaue S, Yamaguchi E et. al.

Feb 16th, 2021 - Pulmonary alveolar proteinosis (PAP) is a devastating lung disease caused by abnormal surfactant homeostasis, with a prevalence of 6-7 cases per million population worldwide. While mutations causing hereditary PAP have been reported, the genetic b...

Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor au...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525969
Orphanet Journal of Rare Diseases; Katayama K, Hirose M et. al.

Sep 30th, 2020 - Anti-granulocyte-macrophage colony-stimulating factor autoantibody (GMAb) has been recognized as a diagnostic biomarker for autoimmune pulmonary alveolar proteinosis (aPAP). The aims of this study were to know the incidence of increased level of s...

see more →

Clinicaltrials.gov  85 results

Expression profiles and potential functions of long noncoding RNAs and mRNAs in autoimm...
https://doi.org/10.18632/aging.202818
Aging Yang Y, Xu W et. al.

Apr 6th, 2021 - Autoimmune pulmonary alveolar proteinosis (APAP) is a rare lung disease that may be associated with surfactant overaccumulation. To assess the function of long noncoding RNAs (lncRNAs) in APAP, we performed microarray analyses to identify differen...

Autoimmune pulmonary alveolar proteinosis and idiopathic pulmonary haemosiderosis: a du...
https://doi.org/10.1136/bcr-2020-241048
BMJ Case Reports; Walsh L, McCarthy C et. al.

Apr 3rd, 2021 - Pulmonary alveolar proteinosis (PAP) is a rare pulmonary condition which leads to excessive accumulation of proteinaceous material within the alveoli. Idiopathic pulmonary haemosiderosis (IPH) is another orphan lung disease and results in recurren...

B cell-activating factors in autoimmune pulmonary alveolar proteinosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7923513
Orphanet Journal of Rare Diseases; Hirose M, Arai T et. al.

Mar 3rd, 2021 - Autoimmune pulmonary alveolar proteinosis (APAP) results from the suppression of granulocyte-macrophage colony-stimulating factor (GM-CSF) signaling by a neutralizing autoantibody against GM-CSF. B cell-activating factor (BAFF) and a proliferation...

Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7884840
Nature Communications; Sakaue S, Yamaguchi E et. al.

Feb 16th, 2021 - Pulmonary alveolar proteinosis (PAP) is a devastating lung disease caused by abnormal surfactant homeostasis, with a prevalence of 6-7 cases per million population worldwide. While mutations causing hereditary PAP have been reported, the genetic b...

Clinical significance of serum anti-granulocyte-macrophage colony-stimulating factor au...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7525969
Orphanet Journal of Rare Diseases; Katayama K, Hirose M et. al.

Sep 30th, 2020 - Anti-granulocyte-macrophage colony-stimulating factor autoantibody (GMAb) has been recognized as a diagnostic biomarker for autoimmune pulmonary alveolar proteinosis (aPAP). The aims of this study were to know the incidence of increased level of s...

see more →